Kari G. Rabe

11.1k total citations · 1 hit paper
151 papers, 5.4k citations indexed

About

Kari G. Rabe is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Kari G. Rabe has authored 151 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Genetics, 67 papers in Pathology and Forensic Medicine and 45 papers in Oncology. Recurrent topics in Kari G. Rabe's work include Chronic Lymphocytic Leukemia Research (82 papers), Lymphoma Diagnosis and Treatment (55 papers) and Pancreatic and Hepatic Oncology Research (30 papers). Kari G. Rabe is often cited by papers focused on Chronic Lymphocytic Leukemia Research (82 papers), Lymphoma Diagnosis and Treatment (55 papers) and Pancreatic and Hepatic Oncology Research (30 papers). Kari G. Rabe collaborates with scholars based in United States, Canada and Israel. Kari G. Rabe's co-authors include Gloria M. Petersen, Suresh T. Chari, Mariza de Andrade, Jeanine E. Ransom, Þorvarður R. Hálfdánarson, Joseph Rubin, Susan L. Slager, Cynthia L. Leibson, Tait D. Shanafelt and Neil E. Kay and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Kari G. Rabe

142 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival

2008 634 citations Kari G. Rabe, Gloria M. Petersen et al. profile →

Peers

Countries citing papers authored by Kari G. Rabe

Since Specialization

Citations

This map shows the geographic impact of Kari G. Rabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari G. Rabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari G. Rabe more than expected).

Fields of papers citing papers by Kari G. Rabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kari G. Rabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari G. Rabe. The network helps show where Kari G. Rabe may publish in the future.

Co-authorship network of co-authors of Kari G. Rabe

This figure shows the co-authorship network connecting the top 25 collaborators of Kari G. Rabe. A scholar is included among the top collaborators of Kari G. Rabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kari G. Rabe. Kari G. Rabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Aberrant heterochromatin silences immune response genes in chronic lymphocytic leukemia 2024 ·SHILAP Revista de lepidopterología ·(unknown), Qianqian Guo, Yuan Gao, Sutapa Sinha, Zhenqing Ye, Weiguo Han, Kari G. Rabe, (unknown), (unknown), Chuanhe Yu, Esteban Braggio, Sameer A. Parikh, Susan L. Slager, Neil E. Kay, Zhiquan Wang	0
2	Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number Alterations 2024 ·Cancers ·(unknown), (unknown), Daniel R. O’Brien, Erik Jessen, Cecília Bonolo de Campos, Nicholas Boddicker, (unknown), Cristine Allmer, Kari G. Rabe, James R. Cerhan, Sameer A. Parikh, Neil E. Kay, Huihuang Yan, Daniel L. Van Dyke, Susan L. Slager, Esteban Braggio	2
3	Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature 2024 ·Blood ·(unknown), Brian Giacopelli, Kari G. Rabe, (unknown), Yue-Zhong Wu, Huihuang Yan, Tait D. Shanafelt, Sameer A. Parikh, Wei Ding, Paul J. Hampel, (unknown), James R. Cerhan, Celine M. Vachon, Neil E. Kay, Curtis A. Hanson, Alexander S. Parker, Esteban Braggio, Susan L. Slager, Christopher C. Oakes	2
4	Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL) 2024 ·Blood Cancer Journal ·Aswin Sekar, (unknown), Sameer A. Parikh, Giulio Genovese, Dennis P. Robinson, Aaron D. Norman, Janet E. Olson, Kari G. Rabe, (unknown), Nicholas Boddicker, Paul J. Hampel, Neil E. Kay, James R. Cerhan, Esteban Braggio, Curtis A. Hanson, Celine M. Vachon, Tait D. Shanafelt, Benjamin L. Ebert, Susan L. Slager	3
5	Risk of Incident Melanoma Among Individuals With Low-Count Monoclonal B-Cell Lymphocytosis 2024 ·Journal of Clinical Oncology ·(unknown), (unknown), Sameer A. Parikh, Sara J. Achenbach, Kari G. Rabe, Aaron D. Norman, Janet E. Olson, Neil E. Kay, Esteban Braggio, Curtis A. Hanson, Celine M. Vachon, James R. Cerhan, (unknown), Tait D. Shanafelt, Susan L. Slager	2
6	Impact of type 2 diabetes on mortality, cause of death, and treatment in chronic lymphocytic leukemia 2023 ·American Journal of Hematology ·(unknown), Cristine Allmer, Klaus Rostgaard, Michael Asger Andersen, (unknown), Caspar da Cunha‐Bang, Sameer A. Parikh, Kari G. Rabe, Henrik Hjalgrim, Henrik Frederiksen, Susan L. Slager, Carsten Utoft Niemann	5
7	Time to second treatment can be used to predict overall survival in chronic lymphocytic leukemia: identifying risk factors to help guide treatment selection 2022 ·Leukemia & lymphoma ·(unknown), Neil E. Kay, Sameer A. Parikh, Kari G. Rabe, Timothy G. Call, José F. Leis, Wei Ding, Susan L. Slager, Jacob D. Soumerai, Lindsey E. Roeker, Anthony R. Mato, Andrew D. Zelenetz	2
8	Associations of history of vaccination and hospitalization due to infection with risk of monoclonal B-cell lymphocytosis 2022 ·Leukemia ·Nicholas Boddicker, Sara J. Achenbach, Sameer A. Parikh, Geffen Kleinstern, Esteban Braggio, Aaron D. Norman, Kari G. Rabe, Celine M. Vachon, Connie Lesnick, Timothy G. Call, Janet E. Olson, James R. Cerhan, Neil E. Kay, Curtis A. Hanson, Tait D. Shanafelt, Susan L. Slager	3
9	Progression and survival of MBL: a screening study of 10 139 individuals 2022 ·Blood ·Susan L. Slager, Sameer A. Parikh, Sara J. Achenbach, Aaron D. Norman, Kari G. Rabe, Nicholas Boddicker, Janet E. Olson, Geffen Kleinstern, Connie Lesnick, Timothy G. Call, James R. Cerhan, Celine M. Vachon, Neil E. Kay, Esteban Braggio, Curtis A. Hanson, Tait D. Shanafelt	13
10	The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL 2021 ·Blood ·Sameer A. Parikh, Kari G. Rabe, Neil E. Kay, Timothy G. Call, Wei Ding, José F. Leis, Saad S. Kenderian, Eli Muchtar, Yucai Wang, Amber B. Koehler, Susan M. Schwager, Connie Lesnick, Geffen Kleinstern, Daniel Van Dyke, Curtis A. Hanson, Esteban Braggio, Susan L. Slager, Tait D. Shanafelt	23
11	Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic Adenocarcinoma 2020 ·Clinical Cancer Research ·Siddhartha Yadav, Pashtoon Murtaza Kasi, William R. Bamlet, (unknown), Eric C. Polley, Chunling Hu, Steven N. Hart, Kari G. Rabe, Nicholas Boddicker, Rohan Gnanaolivu, Kun Y. Lee, (unknown), Gloria M. Petersen, Fergus J. Couch, Robert R. McWilliams	25
12	The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice 2020 ·Cancer Medicine ·Sameer A. Parikh, Sara J. Achenbach, Timothy G. Call, Kari G. Rabe, Wei Ding, José F. Leis, Saad S. Kenderian, Asher Chanan‐Khan, Amber B. Koehler, Susan M. Schwager, Eli Muchtar, Amie Fonder, Kristen McCullough, (unknown), Matthew D. Smith, Susan L. Slager, Neil E. Kay, Heidi D. Finnes, Tait D. Shanafelt	39
13	Infectious lymphadenitis in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: a rare, but important, complication 2014 ·Leukemia & lymphoma ·Deborah A. Bowen, Kari G. Rabe, Susan M. Schwager, Susan L. Slager, Timothy G. Call, David S. Viswanatha, Clive S. Zent	13
14	Mapping of the IRF8 Gene Identifies a 3′UTR Variant Associated with Risk of Chronic Lymphocytic Leukemia but not Other Common Non-Hodgkin Lymphoma Subtypes 2013 ·Cancer Epidemiology Biomarkers & Prevention ·Susan L. Slager, Sara J. Achenbach, Yan W. Asmann, Nicola J. Camp, Kari G. Rabe, Lynn R. Goldin, Timothy G. Call, Tait D. Shanafelt, Neil E. Kay, Julie M. Cunningham, Alice H. Wang, J. Brice Weinberg, Aaron D. Norman, Brian K. Link, José F. Leis, Celine M. Vachon, Mark C. Lanasa, Neil E. Caporaso, Anne J. Novak, James R. Cerhan	12
15	Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia 2010 ·Blood ·Tait D. Shanafelt, Matthew T. Drake, Matthew J. Maurer, Cristine Allmer, Kari G. Rabe, Susan L. Slager, George J. Weiner, Timothy G. Call, Brian K. Link, Clive S. Zent, Neil E. Kay, Curtis A. Hanson, Thomas E. Witzig, James R. Cerhan	104
16	Genetic variation at chromosome 8q24 in osteosarcoma cases and controls 2010 ·Carcinogenesis ·Kari G. Rabe, Sonja I. Berndt, (unknown), Laura Burdett, Matthew Yeager, (unknown), (unknown), (unknown), (unknown), Richard B. Hayes, Robert N. Hoover, Sharon A. Savage, (unknown)	18
17	Polymorphic Variants in Hereditary Pancreatic Cancer Genes Are Not Associated with Pancreatic Cancer Risk 2009 ·Cancer Epidemiology Biomarkers & Prevention ·Robert R. McWilliams, William R. Bamlet, Mariza de Andrade, David N. Rider, Fergus J. Couch, Julie M. Cunningham, Martha Matsumoto, Kari G. Rabe, (unknown), Gloria M. Petersen	5
18	Development and Preliminary Validation of the Cancer Family Impact Scale for Colorectal Cancer 2008 ·Genetic Testing ·Pamela S. Sinicrope, Sally W. Vernon, Pamela M. Diamond, Christi A. Patten, Steven H. Kelder, Kari G. Rabe, Gloria M. Petersen	7
19	Pankreas Kanseri-Diyabetes Mellitus İlişkisi: Kanser Tanısı İle Zamansal İlişkisi ve Prevalansı 2008 ·Gastroenterology ·Suresh T. Chari, Cynthia L. Leibson, Kari G. Rabe, Lawrence J. Timmons, Jeanine E. Ransom, Mariza de Andrade, (unknown)	1
20	The Value of MUTYH Testing in Patients with Early Onset Microsatellite Stable Colorectal Cancer Referred for Hereditary Nonpolyposis Colon Cancer Syndrome Testing 2007 ·Genetic Testing ·Douglas L. Riegert‐Johnson, Ruth Johnson, Kari G. Rabe, Liang Wang, Brittany C. Thomas, Linnea M. Baudhuin, Stephen N. Thibodeau, Lisa A. Boardman	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact